FY13 results on Feb 18, 2014

| Updated on January 29, 2014 Published on January 29, 2014

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 18, 2014, inter-alia, to consider amongst other things, approval of audited financial results for the year ended December 31, 2013 and to recommend dividend, if any, on the equity shares of the Company.

Source : BSE - >

Published on January 29, 2014
This article is closed for comments.
Please Email the Editor